Rhinophyma: Our experience based on a series of 12 cases.

Eur Ann Otorhinolaryngol Head Neck Dis

Clínica Clarós, C/Los Vergós, 31, CP 08017, Barcelona, Spain.

Published: February 2018

Introduction: Rhinophyma is a rare, benign and unsightly disease of the skin of the nose that was first described a very long time ago, as illustrated by portrait of an old man with a bulbous nose holding his grandson, by Ghirlandaio in 1490. It was described for the first time by Ferdinando Hebra Von (1816-1880), as the third stage of rosacea. The objective of this study is to report the author's experience and propose a new treatment option in the management of rhinophyma.

Material And Methods: We describe our experience of rhinophyma based on a retrospective case study.

Results: We identified 12 cases over a 12-year period, with a marked male predominance. The therapeutic approach was the same in all patients, consisting of a combination of dermabrasion, decortication and application of fibrin glue, with a favourable outcome in every case with complete epithelialisation.

Conclusion: Rhinophyma is a rare condition of uncertain pathophysiology. Management is surgical and, in view of the many techniques and procedures proposed, we advocate the slogan "to each his own technique", until a consensus has been reached. Our technique combining dermabrasion, decortication and application of fibrin glue has given very good results.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anorl.2017.08.005DOI Listing

Publication Analysis

Top Keywords

rhinophyma rare
8
dermabrasion decortication
8
decortication application
8
application fibrin
8
fibrin glue
8
rhinophyma
4
rhinophyma experience
4
experience based
4
based series
4
series cases
4

Similar Publications

The nose is a common site for many dermatological disorders and even skin cancers. Herein, we report a case of an elderly man who presented with papular lesions on his nose. A 64-year-old man presented with a cluster of four to five skin-colored papules on his nose for the last two years which were gradually increasing in size.

View Article and Find Full Text PDF

Nasal Tip Cutaneous Metastasis of Hepatocellular Carcinoma: A Case Report.

Clin Cosmet Investig Dermatol

October 2023

Department of Dermatology, Second Affiliated Hospital of Naval Medical University, Shanghai, People's Republic of China.

Background: Cutaneous metastasis is rare in clinical practice, especially that from primary hepatocellular carcinoma (HCC), which is even rarer.

Case Presentation: This report describes a male patient with HCC with cutaneous metastases to the nasal tip. The patient developed a raised nodule at the nasal tip 5 years after surgery for HCC, with surface ulceration and crusting and no obvious symptoms.

View Article and Find Full Text PDF

Introduction: Rhinophyma is a relatively rare form of rosacea, while basal cell carcinoma (BCC) is the most frequent skin cancer in humans - both diseases prevail in the elderly.

Aim: To analyse patients with rhinophyma treated surgically in the Dermatosurgery Unit and look for possible cases with BCC within the rhinophyma.

Material And Methods: We performed a retrospective review of all treated rhinophymas in the Dermatosurgery Unit in 2004-2019.

View Article and Find Full Text PDF

Lung cancer most often metastasizes to the central nervous system, bone and liver. Although metastases to the skin are quite rare, it is estimated that they may be the first clinical manifestation of this disease in 0.7%-12% of cases.

View Article and Find Full Text PDF

Rhinophyma affects predominantly the Caucasian population and is rare in those with Fitzpatrick skin type IV-VI. Diagnosis is based on clinical evaluation. Prominent features include abnormal coloration and texture of skin, impaired vascularity, irregular nodular exophytic growth and telangiectasia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!